Early gastrointestinal cancers
著者
書誌事項
Early gastrointestinal cancers
(Recent results in cancer research, 196)
Springer, c2012
大学図書館所蔵 全3件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references
内容説明・目次
内容説明
This Recent Results in Cancer Research volume contains the majority of the invited expert contributions from the First St. Gallen EORTC Gastrointestinal Cancer Conference, held on 22-24 March 2012 in St. Gallen, Switzerland. Written by some of the world's leading experts in the field, the volume constitutes a comprehensive update on recent developments in the imaging, molecular biology, pathology, and multidisciplinary management of early cancer of the gastrointestinal tract. The latest recommendations regarding diagnosis and treatment are provided, and areas of consensus and controversy, identified. While the principal focus is on esophageal and gastric cancer, advances in the treatment of colorectal and pancreatic cancer are also discussed in some detail. This book will be of interest to every clinician involved in the care of patients with gastrointestinal malignancies.
目次
Clinically relevant study end points in rectal cancer.- Neoadjuvant treatment in rectal cancer: Do we always need radiotherapy?- Treatment dilemmas in patients with synchronous colorectal liver metastases.- Pancreatic surgery: beyond the traditional limits.- Adjuvant therapy for pancreatic cancer.- Radiotherapy of the pancreas: state of the art in 2012.- Adenocarcinoma of the GEJ: gastric or oesophageal cancer?- Why is there a change in patterns of GE cancer?- Open or minimally invasive resection for oesophageal cancer?- Criteria for selecting the best multimodal therapy.- When is the definitive radiochemotherapy the treatment of choice?- Radiotherapy of gastroesophageal junction (GEJ) cancer.- Optimizing neoadjuvant chemotherapy through the use of early response evaluation by PET .- Optimal surgery for gastric cancer: is more always better?- Can adjuvant chemoradiotherapy replace extended lymph node dissection in gastric cancer?- Predicting the response to chemotherapy in gastric adenocarcinoma: who benefits from neoadjuvant chemotherapy?- Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.- Selecting the best treatment for an individual patient.
「Nielsen BookData」 より